ABIONYX Pharma vs CellCentric
ABIONYX Pharma vs CellCentric, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ABIONYX Pharma is on 44/100 and CellCentric on 60/100.
Where each one leads
ABIONYX Pharma
- agent readiness: 43/100 against 32/100
CellCentric
- our overall score: 60/100 against 44/100
- domain rating: 35/100 against 25/100
- funding raised: $375M against $225M
At a glance
| Measure | ABIONYX Pharma | CellCentric |
|---|---|---|
| What it is | Biopharmaceutical company developing innovative therapies for sepsis and intensive care. | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2015 | 2003 |
| Headquarters | Toulouse, France | Cambridge, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | ABIONYX Pharma | CellCentric |
|---|---|---|
| Employees | Not published | 53 |
| Total funding | $225M | $375M |
| Latest round | Capital Increase | Series D |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 28,695 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ABIONYX Pharma | CellCentric |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 60/100 |
| Traction | 40/100 | 57/100 |
| Team | 20/100 | 60/100 |
| Search visibility | 5/100 | 44/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (43/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 35/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ABIONYX Pharma | CellCentric |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
ABIONYX Pharma vs CellCentric: common questions
Which is better, ABIONYX Pharma or CellCentric?
On our 0-100 score CellCentric rates higher (60/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do ABIONYX Pharma and CellCentric compare on the numbers?
ABIONYX Pharma leads on agent readiness (43/100 against 32/100). CellCentric leads on our overall score (60/100 against 44/100), domain rating (35/100 against 25/100), funding raised ($375M against $225M).
Read the full ABIONYX Pharma review and pricing or the CellCentric review and pricing. You can also browse other ABIONYX Pharma alternatives we track.